Ill. Pharma Co. Gets OK For Fast Sale Of Testosterone Drug

By Leslie A. Pappas · September 7, 2022, 5:27 PM EDT

Clarus Therapeutics Inc., a bankrupt manufacturer of a pill that treats low testosterone, received court approval on Wednesday in Delaware bankruptcy court to pay down the interest on its $43 million debt...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Clarus Therapeutics Holdings, Inc.

Case Number

1:22-bk-10845

Court

Delaware

Nature of Suit

Date Filed

September 05, 2022